Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseWoundERE-Luc and MITO-Luc transgenic reporter miceFemalen = n = 4 per group for dose-response, systemic imaging and wou…Local subcutaneous injection into the area surrounding the wound; vehicle corn oil200 microg/kg of 1e or 1f for wound studies; systemic dose-…Immediately after generation of the wound
Model: Full-thickness dorsal skin wound (1 cm incisional wound through skin and panniculus carnosus, and circular full-thickness excisional wound approximately 9 mm diameter)
Compound 1e at 200 microg/kg locally accelerated healing, giving 73 per cent wound area reduction at 72 h versus 60 per cent for 17beta-estradiol and 50 per cent for vehicle, with increased local proliferation, higher granulation histoscore at day 10 and 25 per cent fewer Iba1-positive macrophages.…
Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.